Renaplat Injection 1 mg/ml contains Cisplatin, a platinum-based chemotherapeutic agent widely used in oncology for the treatment of various cancers. Cisplatin works by interfering with DNA replication in cancer cells, preventing their growth and division, which leads to programmed cell death (apoptosis). Renaplat is administered intravenously under strict medical supervision, typically in hospital or clinical settings, due to its potent effects and potential side effects.

Renaplat Injection is indicated for multiple types of malignancies, including testicular, ovarian, bladder, lung, and head and neck cancers, either alone or in combination with other chemotherapy agents.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Key Features and Uses

• Broad Anti-Cancer Activity: Effective against a wide range of solid tumors.

• Combination Therapy: Often used alongside other chemotherapeutic drugs to enhance efficacy.

• Intravenous Administration: Rapid delivery directly into the bloodstream for maximum effect.

• Oncology Standard: Recognized as a first-line therapy for several cancers.

Mechanism of Action

Cisplatin binds to DNA in cancer cells, forming cross-links that interfere with DNA replication and transcription. This damage triggers cell cycle arrest and apoptosis, reducing tumor growth. Its mechanism is highly effective in rapidly dividing cells, making it a cornerstone in many chemotherapy regimens.

Dosage and Administration

• Administration: Intravenous infusion under professional supervision. Direct injection must be avoided to prevent vein irritation.

• Dosage: Determined by the oncologist based on patient body surface area, cancer type, and treatment regimen.

• Hydration: Adequate hydration before and after infusion is essential to reduce kidney toxicity.

• Treatment Cycle: Administered as part of a structured chemotherapy schedule with repeated cycles, depending on cancer type and patient response.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions and Safety

• Allergy Alert: Do not use in patients with known hypersensitivity to Cisplatin or other platinum compounds.

• Kidney Safety: Monitor renal function closely; hydration is critical to prevent nephrotoxicity.

• Hearing Monitoring: Cisplatin may cause ototoxicity; audiometry tests may be required for long-term therapy.

• Pregnancy and Lactation: Contraindicated during pregnancy; discuss breastfeeding risks with a doctor.

• Side Effects: Can include nausea, vomiting, kidney damage, low blood cell counts, hearing loss, neuropathy, or electrolyte imbalances. Severe reactions require immediate medical attention.

• Drug Interactions: May interact with other nephrotoxic, ototoxic, or bone marrow-suppressing agents; consult the oncologist before co-administration.

Storage

• Store at controlled room temperature, 20–25°C.

• Protect from light and do not freeze.

• Keep out of reach of children.

Renaplat Injection 1 mg/ml is a powerful chemotherapy agent, providing effective treatment for various cancers when administered under professional supervision, with careful monitoring of kidney function, blood counts, and overall patient safety.